Scammers Target Nurses Using Faxed Falsified Documents

Jan 9, 2025 | News, Risk Management

Nurses in Texas, including advanced practice registered nurses (APRNs), are being targeted by scammers using a new fraudulent scheme designed to extort money by instilling fear and confusion. These scammers contact nurses by phone, falsely claiming that the Texas...

New Developments: Eli Lilly’s Motion to Intervene in FDA Case

Jan 9, 2025 | News

In an important new development, the United States District Court for the Northern District of Texas has allowed Eli Lilly and Company to intervene in a case that could significantly impact the pharmaceutical and outsourcing facility industries. The case features the...

Ongoing Litigation and Voluntary Submissions: Texas Top Cop Shop, Inc. v. Garland and the Corporate Transparency Act

Jan 6, 2025 | Legal Compliance, News

In the ongoing case of Texas Top Cop Shop, Inc., et al. v. Garland, et al., No. 4:24-cv-00478 (E.D. Tex.), the U.S. District Court for the Eastern District of Texas issued a nationwide preliminary injunction on December 3, 2024, halting the enforcement of the...

Important Update: Beneficial Ownership Information Reporting

Dec 24, 2024 | Legal Compliance, News

Recent legal developments have altered the timeline for beneficial ownership information (BOIR) reporting requirements under the Corporate Transparency Act (CTA), including the deadlines for initial filings and extensions granted due to legal challenges. On December...

FDA Declares Zepbound No Longer in Shortage: A Legal Perspective on the Implications for Patients, Pharmacies, and the Industry

Dec 19, 2024 | News

On December 19, 2024, the U.S. Food and Drug Administration (FDA) made a critical ruling that has major legal and regulatory consequences for the healthcare sector. The FDA declared that the shortage of tirzepatide, the active ingredient in Eli Lilly’s weight loss...

Breaking News: FDA Reevaluates Tirzepatide Drug Shortage: A Win for the Aesthetics Industry and Compounding Pharmacies

Nov 21, 2024 | News

The U.S. District Court for the Northern District of Texas recently released a joint status report in the case Outsourcing Facilities Association v. U.S. Food and Drug Administration (Case No. 4:24-cv-00953-P). This report, filed on November 21, 2024, outlines ongoing...